insights_auto
Pse është rritur BRM 2,10%?
Zhytu më thellëchevron_right
BRM:FRA
Bristol-Myers Squibb Co
51,53 €
arrow_upward
+2,10%(+1,06) 1D
14 tet, 10:00:00 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për BRM...
Hap
50,51 €
I lartë
51,53 €
I ulët
50,51 €
Kapitalizimi i tregut
121,09 mld
Vëllimi mesatar
224,00
Vëllimi
40,00
Maksimumi 52-javor
60,64 €
Minimumi 52-javor
36,65 €
Numri i punonjësve
32 mijë
Hap
50,51 €
I lartë
51,53 €
I ulët
50,51 €
Kapitalizimi i tregut
121,09 mld
Vëllimi mesatar
224,00
Vëllimi
40,00
Maksimumi 52-javor
60,64 €
Minimumi 52-javor
36,65 €
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
MarketWatch
·
2 orë më parë
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
MarketBeat
·
3 orë më parë
Bristol Myers Squibb (NYSE:BMY) Shares Up 4% - What's Next?
ad-hoc-news.de
·
9 orë më parë
Wells Fargo cuts target for Bristol Myers Squibb stock to USD 60.00
Yahoo Finance
·
11 orë më parë
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Profili
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Rreth Bristol-Myers Squibb Co
Drejtori ekzekutivChris Boerner
Punonjësit32,5 mijë
Themeluar më1887
SeliaNew York City, New York, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtibms.com